Reuters logo
BRIEF-Delmar Pharmaceuticals initiates phase 2 clinical trial
2017年9月11日 / 上午9点07分 / 2 个月前

BRIEF-Delmar Pharmaceuticals initiates phase 2 clinical trial

Sept 11 (Reuters) - Delmar Pharmaceuticals Inc-

* Delmar Pharmaceuticals initiates phase 2 clinical trial in newly diagnosed MGMT-unmethylated glioblastoma multiforme

* Delmar Pharmaceuticals- clinical trial will explore safety of chemoradiation with VAL-083 as alternative to standard-of-care temozolomide in patients Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below